Home › Meningioma › Florida
Meningioma clinical trials in Florida
7 studies for Meningioma are looking for participants at sites in Florida.
Cities in Florida
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- Boca Raton Regional Hospital, Boca Raton
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- Holy Cross Hospital, Fort Lauderdale
- and 6 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT02523014Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
- Baptist MD Anderson Cancer Center, Jacksonville
- University of Miami, Miami
- Baptist Health Medical Group Oncology, Miami
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06955169A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- Mayo Clinic_Jacksonville, Jacksonville
- Baptist Health Miami Cancer Institute, Miami
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT07428616Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
- University of Miami, Miami
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 2, 2026 · NCT04374305Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- BayCare Health, Clearwater
- Ascension St. Vincent's, Jacksonville
- Miami Cancer Institute, Baptist Health South Florida, Miami
- and 4 more
RecruitingObservational study
All ages · All sexes · Updated Jul 22, 2026 · NCT04427384Cabozantinib for Patients With Recurrent or Progressive Meningioma
- Miami Cancer Institute at Baptist Health, Inc., Miami
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT05425004Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
- Mayo Clinic, Jacksonville
- Biogenix Molecular, Miami
RecruitingPhase 1/2
Ages 18 to 90 · All sexes · Updated May 14, 2026 · NCT05636618From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.